SG10201507120TA - Treatment of diseases - Google Patents

Treatment of diseases

Info

Publication number: SG10201507120TA
Authority: SG; Singapore
Prior art keywords: diseases; treatment
Prior art date: 2010-09-07

Application number

SG10201507120TA

Inventor

David Bar-Or

Original Assignee

Ampio Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-09-07

Filing date

2011-09-07

Publication date

2015-10-29

2011-09-07 Application filed by Ampio Pharmaceuticals Inc filed Critical Ampio Pharmaceuticals Inc

2015-10-29 Publication of SG10201507120TA publication Critical patent/SG10201507120TA/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Vascular Medicine (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

SG10201507120TA 2010-09-07 2011-09-07 Treatment of diseases SG10201507120TA (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US38040410P	2010-09-07	2010-09-07

Publications (1)

Publication Number	Publication Date
SG10201507120TA true SG10201507120TA (en)	2015-10-29

Family

ID=45771136

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SG2013015680A SG187986A1 (en)	2010-09-07	2011-09-07	Treatment of diseases
SG10201507120TA SG10201507120TA (en)	2010-09-07	2011-09-07	Treatment of diseases

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
SG2013015680A SG187986A1 (en)	2010-09-07	2011-09-07	Treatment of diseases

Country Status (18)

Country	Link
US (3)	US20120058934A1 (en)
EP (1)	EP2613795B1 (en)
JP (2)	JP5941047B2 (en)
KR (1)	KR101822951B1 (en)
CN (1)	CN103200952B (en)
AU (1)	AU2011299353B2 (en)
BR (1)	BR112013005432A8 (en)
CA (1)	CA2810834C (en)
CO (1)	CO6710904A2 (en)
EA (1)	EA023932B1 (en)
ES (1)	ES2611878T3 (en)
HK (1)	HK1182617A1 (en)
IL (1)	IL224931A (en)
MX (1)	MX343160B (en)
NZ (1)	NZ607600A (en)
SG (2)	SG187986A1 (en)
WO (1)	WO2012033789A2 (en)
ZA (1)	ZA201301601B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE547101T1 (en) *	2000-08-04	2012-03-15	Dmi Biosciences Inc	METHOD OF USE OF DIKETOPIPERAZINES AND COMPOSITIONS CONTAINING SAME
AU2004241101B2 (en) *	2003-05-15	2010-05-13	Ampio Pharmaceuticals, Inc.	Treatment of T-cell mediated diseases
WO2009146320A1 (en)	2008-05-27	2009-12-03	Dmi Life Sciences, Inc.	Therapeutic methods and compounds
CA2810844C (en)	2010-09-07	2017-03-21	Dmi Acquisition Corp.	Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions
CA2810834C (en) *	2010-09-07	2017-03-21	Dmi Acquisition Corp.	Use of diketopiperazines for inhibiting vascular hyperpermeability
US9925300B2 (en)	2011-10-10	2018-03-27	Ampio Pharmaceuticals, Inc.	Implantable medical devices with increased immune tolerance, and methods for making and implanting
MY167804A (en)	2011-10-10	2018-09-26	Ampio Pharmaceuticals Inc	Treatment of degenerative joint disease
SG11201400283RA (en)	2011-10-28	2014-03-28	Ampio Pharmaceuticals Inc	Treatment of rhinitis
AU2014232728B2 (en)	2013-03-15	2019-02-21	Ampio Pharmaceuticals, Inc.	Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
CN105307514B (en)	2013-06-10	2018-11-27	三得利控股株式会社	Plant extracts and its manufacturing method containing diketopiperazine
CN103913853A (en) *	2013-07-05	2014-07-09	马准吾	Contact lens having cooling coating layer
EP4066836A1 (en)	2014-08-18	2022-10-05	Ampio Pharmaceuticals, Inc.	Treatment of joint conditions
US11389512B2 (en)	2015-06-22	2022-07-19	Ampio Pharmaceuticals, Inc.	Use of low molecular weight fractions of human serum albumin in treating diseases
EP3329928A4 (en)	2015-07-27	2019-05-01	Suntory Holdings Limited	Composition containing cyclic dipeptide and sweetening agent
KR102396603B1 (en)	2015-09-16	2022-05-11	원광대학교산학협력단	Composition for improving liver function comprising citrulline as an active ingredient
CN105879005A (en) *	2016-02-01	2016-08-24	四川好医生攀西药业有限责任公司	Pharmaceutical composition for treating ulcerative colitis as well as preparation method and application of pharmaceutical composition
US20190240296A1 (en) *	2016-07-26	2019-08-08	Ampio Pharmaceuticals, Inc.	Treatment of diseases mediated by vascular hyperpermeability
CA3072427C (en)	2017-08-08	2023-12-05	Fresenius Medical Care Holdings, Inc.	Systems and methods for treating and estimating progression of chronic kidney disease
JP6741280B2 (en) *	2018-03-29	2020-08-19	株式会社ウォーターエージェンシー	Composition used for ACE inhibition, suppression of blood pressure increase, or blood pressure reduction, and method for producing the same
US11129878B1 (en)	2020-03-24	2021-09-28	Ampio Pharmaceuticals, Inc.	Methods for treating diseases associated with respiratory viruses
CN113754598B (en) *	2021-09-29	2023-06-06	四川大学	Diamine and polyimide containing cyclic peptide structure and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2000327575A (en) *	1999-05-26	2000-11-28	Teika Seiyaku Kk	Remedy for inflammatiory disease containing diketopiperazine derivative and new diketopiperazine derivative
ATE547101T1 (en) *	2000-08-04	2012-03-15	Dmi Biosciences Inc	METHOD OF USE OF DIKETOPIPERAZINES AND COMPOSITIONS CONTAINING SAME
CN101279094A (en) *	2003-05-15	2008-10-08	Dmi生物科学公司	Treatment of T-cell mediated diseases
AU2004241101B2 (en) *	2003-05-15	2010-05-13	Ampio Pharmaceuticals, Inc.	Treatment of T-cell mediated diseases
CN101808515A (en) *	2007-09-25	2010-08-18	雅培制药有限公司	Octahydropentalene compounds as chemokine receptor antagonists
WO2009146320A1 (en) *	2008-05-27	2009-12-03	Dmi Life Sciences, Inc.	Therapeutic methods and compounds
CA2810844C (en) *	2010-09-07	2017-03-21	Dmi Acquisition Corp.	Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions
CA2810834C (en) *	2010-09-07	2017-03-21	Dmi Acquisition Corp.	Use of diketopiperazines for inhibiting vascular hyperpermeability

2011
- 2011-09-07 CA CA2810834A patent/CA2810834C/en not_active Expired - Fee Related
- 2011-09-07 EP EP11824038.1A patent/EP2613795B1/en not_active Not-in-force
- 2011-09-07 MX MX2013002566A patent/MX343160B/en active IP Right Grant
- 2011-09-07 KR KR1020137008193A patent/KR101822951B1/en active IP Right Grant
- 2011-09-07 NZ NZ607600A patent/NZ607600A/en not_active IP Right Cessation
- 2011-09-07 SG SG2013015680A patent/SG187986A1/en unknown
- 2011-09-07 SG SG10201507120TA patent/SG10201507120TA/en unknown
- 2011-09-07 EA EA201390347A patent/EA023932B1/en not_active IP Right Cessation
- 2011-09-07 ES ES11824038.1T patent/ES2611878T3/en active Active
- 2011-09-07 CN CN201180053553.8A patent/CN103200952B/en not_active Expired - Fee Related
- 2011-09-07 US US13/227,098 patent/US20120058934A1/en not_active Abandoned
- 2011-09-07 AU AU2011299353A patent/AU2011299353B2/en not_active Ceased
- 2011-09-07 JP JP2013528256A patent/JP5941047B2/en not_active Expired - Fee Related
- 2011-09-07 BR BR112013005432A patent/BR112013005432A8/en not_active IP Right Cessation
- 2011-09-07 WO PCT/US2011/050612 patent/WO2012033789A2/en active Application Filing
2013
- 2013-02-26 IL IL224931A patent/IL224931A/en active IP Right Grant
- 2013-03-01 ZA ZA2013/01601A patent/ZA201301601B/en unknown
- 2013-04-05 CO CO13089531A patent/CO6710904A2/en unknown
- 2013-08-23 HK HK13109875.6A patent/HK1182617A1/en not_active IP Right Cessation
2016
- 2016-05-19 JP JP2016100487A patent/JP2016145261A/en active Pending
2019
- 2019-09-25 US US16/582,953 patent/US20200016152A1/en not_active Abandoned
2020
- 2020-11-05 US US17/090,673 patent/US20210052578A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CO6710904A2 (en)	2013-07-15
BR112013005432A2 (en)	2016-06-07
BR112013005432A8 (en)	2017-12-05
NZ607600A (en)	2015-05-29
MX2013002566A (en)	2013-06-18
CA2810834C (en)	2017-03-21
JP2016145261A (en)	2016-08-12
KR101822951B1 (en)	2018-01-29
IL224931A (en)	2017-05-29
HK1182617A1 (en)	2013-12-06
US20210052578A1 (en)	2021-02-25
AU2011299353B2 (en)	2016-02-25
EP2613795A2 (en)	2013-07-17
CN103200952B (en)	2016-04-06
JP5941047B2 (en)	2016-06-29
ZA201301601B (en)	2018-12-19
US20120058934A1 (en)	2012-03-08
EP2613795A4 (en)	2013-10-30
EA023932B1 (en)	2016-07-29
ES2611878T3 (en)	2017-05-11
MX343160B (en)	2016-10-26
WO2012033789A2 (en)	2012-03-15
AU2011299353A1 (en)	2013-03-14
KR20140003399A (en)	2014-01-09
SG187986A1 (en)	2013-03-28
WO2012033789A3 (en)	2012-05-31
CA2810834A1 (en)	2012-03-15
CN103200952A (en)	2013-07-10
JP2013537194A (en)	2013-09-30
US20200016152A1 (en)	2020-01-16
EP2613795B1 (en)	2016-10-26
EA201390347A1 (en)	2013-07-30

Publication	Publication Date	Title
ZA201301601B (en)	2018-12-19	Treatment of diseases
EP2613786A4 (en)	2013-10-23	Treatment of diseases
ZA201304280B (en)	2014-08-27	Treatment of jak2-mediated conditions
EP2621499A4 (en)	2014-04-09	Methods for the treatment of allergic diseases
IL220876A0 (en)	2012-09-24	Treatment of cardiac conditions
EP2723384A4 (en)	2015-08-12	Treatment of proteinopathies
EP2605827A4 (en)	2015-08-05	Non-invasive treatment of bronchial constriction
HK1217763A1 (en)	2017-01-20	Methods of treating diseases
SG10201508495VA (en)	2015-11-27	Combination treatment of cancer
ZA201300218B (en)	2013-09-25	Treatment of blood cancer
EP2623494A4 (en)	2014-04-02	Agent for treatment of eye diseases
HK1199261A1 (en)	2015-06-26	Methods for treatment of diseases
IL256026A (en)	2018-01-31	Methods of treatment
EP2640220A4 (en)	2014-10-08	Treatment of nail disease
IL225896A0 (en)	2013-06-27	Treatment of mecp2-associated disorders
EP2544686A4 (en)	2013-06-26	Combination methods for treatment of disease
ZA201208389B (en)	2013-06-26	Treatment of proliferative diseases
EP2608804A4 (en)	2015-03-11	Treatment of renal diseases
EP2522360A4 (en)	2013-10-02	Vaccine for treatment of tautopathy
EP2556161A4 (en)	2013-11-06	Methods for the treatment of autoimmune diseases
GB201107467D0 (en)	2011-06-15	Novel treatment of pain
IL222690A0 (en)	2012-12-31	Treatment of autoimmune diseases
EP2625180A4 (en)	2014-05-14	Porphyrin treatment of neurodegenerative diseases
GB201009194D0 (en)	2010-07-14	Treatment of pain
ZA201008686B (en)	2012-01-25	Treatment of animals